🇧🇷 Brazil Clinical Trials Database
Search 13,000+ clinical trials conducted in Brazil. Access comprehensive trial data including phases, sponsors, outcomes, and locations from ReBEC & International Registries. Part of Pure Global AI's free database with 840,000+ trials worldwide.
What is the Brazil clinical trials database?
The Brazil clinical trials database contains over 13,000 clinical trials registered in Brazil through ReBEC (Registro Brasileiro de Ensaios Clínicos) and international registries. Brazil is Latin America's largest pharmaceutical market.
How do I search for clinical trials in Brazil?
Enter a disease name, drug name, sponsor, or trial ID in the search box. Results include trials conducted in Brazil registered in multiple national and international registries.
What regulatory body oversees clinical trials in Brazil?
ANVISA (Agência Nacional de Vigilância Sanitária) oversees clinical trials in Brazil along with CONEP (National Research Ethics Commission) for ethical approval.
Is this database free to use?
Yes, this database is completely free. Pure Global AI provides free access to help researchers and companies navigate Brazilian clinical research.
What types of trials are common in Brazil?
Brazil has significant trials in tropical diseases (dengue, Zika, Chagas), oncology, cardiovascular disease, and vaccines. The diverse population makes Brazil attractive for global clinical development.
How does Brazil fit in Latin American clinical trials?
Brazil conducts more clinical trials than any other Latin American country. It offers a large patient population, established research infrastructure, and is often included in global Phase 3 programs.
About This Database
This database provides free access to clinical trial data from Brazil. Brazil is Latin America's largest healthcare market with a diverse population of 215+ million. Use this tool to research the Brazilian market, find ANVISA trial opportunities, understand local regulatory requirements, and track drug/device development in this key emerging market.